Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

10-08-2022

Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …

Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board

Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board

20-07-2022

On July 14, Prince Constantijn of the Netherlands succeeded Robbert Dijkgraaf as chairman of the Supervisory Board of Hartwig Medical …

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

14-04-2022

The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …

In the media: Rarity – Personalised cancer treatment – fact not fiction

In the media: Rarity – Personalised cancer treatment – fact not fiction

28-02-2022

Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …

Novel catalog interface Hartwig Medical Database with whole genome sequenced tumor genomes

Novel catalog interface Hartwig Medical Database with whole genome sequenced tumor genomes

22-02-2022

Hartwig Medical Foundation has presented a novel catalog interface of the Hartwig Medical Database with whole genome sequenced tumor genomes: https://catalog.hartwigmedicalfoundation.nl. …

Complete DNA analysis for young adults with cancer

Complete DNA analysis for young adults with cancer

06-01-2022

KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …

Single WGS analysis of metastases is sufficient in most cases

Single WGS analysis of metastases is sufficient in most cases

26-10-2021

DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

10-08-2021

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region

01-08-2021

The Erasmus MC Cancer Institute has started using comprehensive DNA testing for carcinoma of unknown primary (CUP) cancer patients in …

ASCO 2021: Presentations about whole genome sequencing

ASCO 2021: Presentations about whole genome sequencing

19-06-2021

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk …

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

27-05-2021

Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

Measuring the effects of radiotherapy on cancer may open up avenues for treatment

21-05-2021

Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …

Back to Latest news

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl